Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

Health System Planning

09.06.2026

Daraxonrasib Pancreatic Cancer Pill Doubles Survival

Daraxonrasib Pancreatic Cancer Pill nearly doubled survival in metastatic PDAC, beating second-line chemo with fewer discontinuations.

Search the archive

Browse by month

Archives